Ratings by H.C. Wainwright (Michael King)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/23/2022 | Scholar Rock | SRRK | New Coverage | Buy (N/A) |
12.99 (14.79) |
13.86% | Details | |
| 3/11/2022 | Lantern Pharma Inc. | LTRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Lantern Pharma Inc. | LTRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
3.25 (1.52) |
-53.23% | Details | |
| 10/11/2021 | Cogent | COGT | New Coverage | Buy (N/A) |
7.60 (6.96) |
-8.42% | Details | |
| 10/7/2021 | Lantern Pharma Inc. | LTRN | New Coverage | Buy (N/A) |
9.49 (5.77) |
-39.2% | Details | |
| 8/25/2021 | Salarius Pharmaceuticals | SLRX | New Coverage | Buy (N/A) |
0.94 (0.50) |
-46.81% | Details | |
| 6/29/2021 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
542.70 (907.32) |
67.19% | Details | |
| 6/15/2021 | Exelixis | EXEL | New Coverage | Buy (N/A) |
22.76 (23.29) |
2.33% | Details | |
| 5/25/2021 | Werewolf Therapeutics Inc. | HOWL | New Coverage | Buy (N/A) |
12.18 (6.44) |
-47.13% | Details |
